Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$300.57M
↑ 450% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
$-85.96M
Historical baseline
PeriodValueYoY Change
TTM$300.57M+205.6%
2025$98.35M+116.4%
2024$-601.08M-193.2%
2023$-205.00M-14.8%
2022$-178.51M-19.8%
2021$-149.04M-60.0%
2020$-93.16M-252.2%
2019$61.19M+209.4%
2018$-55.94M-51.2%
2017$-37.00M-